Silverfin false false 31/03/2026 01/04/2025 31/03/2026 M J Hood 11/06/2025 24/01/2025 T B Kress 11/06/2025 U And I Director 1 Limited 11/06/2025 24/01/2025 U And I Director 2 Limited 11/06/2025 24/01/2025 07 October 2026 The principal activity of the company is to create workspaces that unlock potential, driving business growth and innovation, community collaboration and positive social impact. 09608957 2026-03-31 09608957 bus:Director1 2026-03-31 09608957 bus:Director2 2026-03-31 09608957 bus:Director3 2026-03-31 09608957 bus:Director4 2026-03-31 09608957 2025-03-31 09608957 core:CurrentFinancialInstruments 2026-03-31 09608957 core:CurrentFinancialInstruments 2025-03-31 09608957 core:Non-currentFinancialInstruments 2026-03-31 09608957 core:Non-currentFinancialInstruments 2025-03-31 09608957 core:ShareCapital 2026-03-31 09608957 core:ShareCapital 2025-03-31 09608957 core:RetainedEarningsAccumulatedLosses 2026-03-31 09608957 core:RetainedEarningsAccumulatedLosses 2025-03-31 09608957 core:CostValuation 2025-03-31 09608957 core:CostValuation 2026-03-31 09608957 core:ImmediateParent core:CurrentFinancialInstruments 2026-03-31 09608957 core:ImmediateParent core:CurrentFinancialInstruments 2025-03-31 09608957 bus:OrdinaryShareClass1 2026-03-31 09608957 2025-04-01 2026-03-31 09608957 bus:FilletedAccounts 2025-04-01 2026-03-31 09608957 bus:SmallEntities 2025-04-01 2026-03-31 09608957 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 09608957 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 09608957 bus:Director1 2025-04-01 2026-03-31 09608957 bus:Director2 2025-04-01 2026-03-31 09608957 bus:Director3 2025-04-01 2026-03-31 09608957 bus:Director4 2025-04-01 2026-03-31 09608957 2024-04-01 2025-03-31 09608957 bus:OrdinaryShareClass1 2025-04-01 2026-03-31 09608957 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 09608957 (England and Wales)

CENTRAL RESEARCH LABORATORY (HAYES) LTD

Unaudited Financial Statements
For the financial year ended 31 March 2026
Pages for filing with the registrar

CENTRAL RESEARCH LABORATORY (HAYES) LTD

Unaudited Financial Statements

For the financial year ended 31 March 2026

Contents

CENTRAL RESEARCH LABORATORY (HAYES) LTD

STATEMENT OF FINANCIAL POSITION

As at 31 March 2026
CENTRAL RESEARCH LABORATORY (HAYES) LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 March 2026
Note 2026 2025
£ £
Fixed assets
Investments 3 17 17
17 17
Current assets
Debtors 4 188,570 274,885
Cash at bank and in hand 17,529 7,157
206,099 282,042
Creditors: amounts falling due within one year 5 ( 31,669) ( 97,643)
Net current assets 174,430 184,399
Total assets less current liabilities 174,447 184,416
Creditors: amounts falling due after more than one year 6 0 ( 8,772)
Net assets 174,447 175,644
Capital and reserves
Called-up share capital 7 1 1
Profit and loss account 174,446 175,643
Total shareholder's funds 174,447 175,644

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Central Research Laboratory (Hayes) Ltd (registered number: 09608957) were approved and authorised for issue by the Director. They were signed on its behalf by:

T B Kress
Director

07 October 2026

CENTRAL RESEARCH LABORATORY (HAYES) LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2026
CENTRAL RESEARCH LABORATORY (HAYES) LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2026
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Central Research Laboratory (Hayes) Ltd (the company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the company's registered office is 167-169 Great Portland Street, London, W1W 5PF, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the company and rounded to the nearest £.

Going concern

The director has assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the reporting date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business and is shown net of VAT and other sales related taxes.

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract.

Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Defined contribution schemes
The company operates a defined contribution scheme. The amount charged to the Statement of Income and Retained Earnings in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Statement of Financial Position.

Finance costs

Finance costs are charged to the Statement of Income and Retained Earnings over the term of the debt using the effective interest method so the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets is reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

The Company only enters into basic financial instruments and transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to and from related parties and investments in non-puttable ordinary shares.

Financial assets
Basic financial assets, including trade and other debtors, and amounts due from related companies, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest method.

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in the Statement of Income and Retained Earnings.

Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.

Financial liabilities
Basic financial liabilities, including trade and other creditors and accruals, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2026 2025
Number Number
Monthly average number of persons employed by the company during the year, including the director 2 3

3. Fixed asset investments

Other investments Total
£ £
Cost or valuation before impairment
At 01 April 2025 17 17
At 31 March 2026 17 17
Carrying value at 31 March 2026 17 17
Carrying value at 31 March 2025 17 17

4. Debtors

2026 2025
£ £
Trade debtors 79,084 60,000
Amounts owed by parent undertakings 39,850 0
Accrued income 69,618 203,401
VAT recoverable 0 11,484
Other debtors 18 0
188,570 274,885

Amounts owed by parent undertakings are unsecured, interest-free, have no fixed date of repayment and are repayable on demand.

5. Creditors: amounts falling due within one year

2026 2025
£ £
Bank loans 8,773 10,289
Trade creditors 10,371 1,352
Amounts owed to parent undertakings 0 74,924
Other taxation and social security 10,525 2,098
Other creditors 2,000 8,980
31,669 97,643

Amounts owed to parent undertakings are unsecured, interest-free, have no fixed date of repayment and are repayable on demand.

6. Creditors: amounts falling due after more than one year

2026 2025
£ £
Bank loans 0 8,772

7. Called-up share capital

2026 2025
£ £
Allotted, called-up and fully-paid
1 Ordinary share of £ 1.00 1 1

8. Related party transactions

Where possible the company has taken advantage of the exemption conferred by section 33.1A of FRS 102 from the requirement to disclose transactions with other wholly owned group undertakings.

9. Ultimate controlling party

Parent Company:

Plus X Holdings Ltd
167-169 Great Portland Street, 5th Floor, London, W1W 5PF